SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-08-020943
Filing Date
2008-04-01
Accepted
2008-04-01 11:53:08
Documents
1
Period of Report
2008-03-28

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION b69439ds.html 4  
1 MAIN DOCUMENT DESCRIPTION b69439ds.xml 4 20405
  Complete submission text file 0001209191-08-020943.txt   22386
Mailing Address 122 WEST 42ND STREET SUITE 2606 NEW YORK NY 10168
Business Address 122 WEST 42ND STREET SUITE 2606 NEW YORK NY 10168 212-682-3096
Lev Pharmaceuticals Inc (Issuer) CIK: 0001144062 (see all company filings)

IRS No.: 880211496 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address C/O MAST MANAGEMENT CAPITAL LLC 535 BOYLSTON STREET, SUITE 401 BOSTON MA 02116
Business Address 617-375-3000
Steinberg David J. (Reporting) CIK: 0001429076 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-32947 | Film No.: 08728056